pharmacopeia

Muscular Weakness

55 drugs19,079 FAERS reportsMedDRA PT
GET
/api/v1/reaction/muscular-weakness
Reference statistics only. FAERS reports are voluntarily submitted and are not incidence rates, safety signals, or causal evidence. The drugs below are ranked by how often this reaction appears on FAERS reports for each drug — high share does not mean the drug caused the reaction, and absence from this list does not mean the reaction never occurred. This is not a symptom checker.

DefinitionNLM MeSH D018908

A vague complaint of debility, fatigue, or exhaustion attributable to weakness of various muscles. The weakness can be characterized as subacute or chronic, often progressive, and is a manifestation of many muscle and neuromuscular diseases. (From Wyngaarden et al., Cecil Textbook of Medicine, 19th ed, p2251)

Source: U.S. National Library of Medicine — MeSH (Muscle Weakness)

Drugs reporting Muscular Weakness (55)

Share = reports listing this reaction ÷ total matched reports for the drug. — means the upstream totals query failed at ingest and the denominator is unknown.

  1. 1Estriol36722%
  2. 2Cobamamide114%
  3. 3Euphorbia Resinifera Resin114%
  4. 4Ferrous Cysteine Glycinate114%
  5. 5Magnesium Ascorbate114%
  6. 6Nadh114%
  7. 7Pyridoxal114%
  8. 8Threonate114%
  9. 9Zinc Ascorbate114%
  10. 10Dichlorphenamide1619.9%
  11. 11Uric Acid29.1%
  12. 12Amyl Nitrite58.3%
  13. 13Botulinum Toxin Type A9507.9%
  14. 14Tyramine27.4%
  15. 15Dordaviprone37.0%
  16. 16Amifampridine1836.6%
  17. 17Tetracycline1106.0%
  18. 18Nelarabine555.8%
  19. 19Efgartigimod Alfa2095.1%
  20. 20Aliskiren2894.9%
  21. 21Peramivir74.5%
  22. 22Pyridostigmine4654.5%
  23. 23Repotrectinib104.3%
  24. 24Acetohydroxamic Acid24.3%
  25. 25Taletrectinib24.3%
  26. 26Methacholine34.2%
  27. 27Pentazocine24.2%
  28. 28Dalfampridine2,7853.9%
  29. 29Ravulizumab4683.8%
  30. 30Risdiplam1423.6%
  31. 31Adefovir433.4%
  32. 32Tofersen163.4%
  33. 33Riluzole673.2%
  34. 34Dantrolene553.2%
  35. 35Pindolol243.1%
  36. 36Edaravone422.8%
  37. 37Teriflunomide1,2712.8%
  38. 38Alglucosidase Alfa652.8%
  39. 39Siponimod2432.8%
  40. 40Corticotropin292.7%
  41. 41Ocrelizumab1,6652.7%
  42. 42Satralizumab422.7%
  43. 43Vamorolone382.7%
  44. 44Halcinonide52.6%
  45. 45Bempedoic Acid782.6%
  46. 46Natalizumab4,5992.6%
  47. 47Butorphanol72.2%
  48. 48Gallium92.1%
  49. 49Carteolol72.1%
  50. 50Gozetotide92.1%
  51. 51Interferon Beta-1a4,0842.1%
  52. 52Ponesimod61.9%
  53. 53Nusinersen1381.8%
  54. 54Bupivacaine2901.7%
  55. 55Lasmiditan171.5%

Related reactions

Other reactions most often co-reported on the same drug set. Ranked by Jaccard similarity over drug-id sets — pure data-derived co-occurrence, not a clinical relationship.

Literature

Recent PubMed references pinned to Muscle Weakness as a MeSH major topic. About the reaction term itself — not about any specific drug.

Note. FAERS reports are voluntarily submitted and are NOT incidence rates, signals, or causal evidence. Counts reflect reporting volume, not how often a reaction occurs. Reference statistics only.

Search pharmacopeia

Search drugs, classes, and ingredients